Foralumab is the only fully human anti-CD3 monoclonal antibody in clinical development for intranasal delivery. By modulating ...

Alira Health, a global healthcare consulting and research organization, today released its fifth annual report on the state of the contract development and manufacturing organization (CDMO) market in ...

Hawthorne, NY, May 15, 2025 (GLOBE NEWSWIRE) -- In a bold step toward transforming modern medicine, OmniMD announces the launch of AI Clinicians, an intelligent clinical companion designed to elevate ...

Presentation scheduled for Thursday, May 15, 2025, at 11:36 a.m. PT ...

“In conjunction with the official launch, we’re excited to announce our partnership with NovaBone Products, one of our industry’s leading innovators,” noted Yager. “This collaboration reflects our ...

As part of Elucent’s mission to lead innovation in real-time localization and surgical guidance for soft tissue excision in the treatment of cancer and other diseases, the EnVisio X1 platform sets a ...

GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE ® natural killer (NK) ...

The development of Phenesafe AI is driven by PharmAla’s drug development philosophy: ...

SAN DIEGO and LONDON and DUBLIN and SYDNEY, May 15, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the ...

Dover, Delaware, May 15, 2025 (GLOBE NEWSWIRE) -- Riti, a wellness company producing dietary supplements, announced that its testosterone support product, T-Booster, has been ranked #3 on News Watch ...

Company surpasses 450 accounts across 24 countries as global demand for fingerprint drug testing surges ...

By restoring balance in your gut microbiome, probiotics help you feel lighter, less gassy, and more regular. Science backs ...